These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7504630)

  • 1. PCA 50941, a novel Ca2+ channel agonist.
    Priego J; González-Morales MA; Cillero FJ; Villarroya M; Sunkel C; de Casa-Juana MF; López MG; Artalejo CR; de Pascual R; García AG
    Eur J Pharmacol; 1993 Oct; 243(1):25-34. PubMed ID: 7504630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Ca2+, PCA50941 and Bay K 8644 in bovine chromaffin cells.
    Montiel C; de la Fuente MT; Vinet R; del Valle M; Gandía L; Artalejo AR; García AG
    Eur J Pharmacol; 1994 Aug; 268(3):293-303. PubMed ID: 7528677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.
    Sunkel CE; Fau de Casa-Juana M; Santos L; García AG; Artalejo CR; Villarroya M; González-Morales MA; López MG; Cillero J; Alonso S
    J Med Chem; 1992 Jun; 35(13):2407-14. PubMed ID: 1377748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RS 30026: a potent and effective calcium channel agonist.
    Patmore L; Duncan GP; Clarke B; Anderson AJ; Greenhouse R; Pfister JR
    Br J Pharmacol; 1990 Apr; 99(4):687-94. PubMed ID: 1694461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
    Takeda Y
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antagonism of calcium channel activators by fluspirilene.
    Kenny BA; Fraser S; Kilpatrick AT; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different sensitivities to dihydropyridines of catecholamine release from cat and ox adrenals.
    Gandía L; Michelena P; de Pascual R; López MG; García AG
    Neuroreport; 1990 Oct; 1(2):119-22. PubMed ID: 1717038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
    Motomura S; Hashimoto K; Hashimoto K
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1-induced vascular contractions: interactions with drugs affecting the calcium channel.
    Stasch JP; Kazda S
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S63-6; discussion S74. PubMed ID: 2473330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
    Franckowiak G; Bechem M; Schramm M; Thomas G
    Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
    Moreau R; Oberti F; Lahaye P; Gadano A; Cailmail S; Sogni P; Cales P; Lebrec D
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1254-8. PubMed ID: 9918435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of palmitoyl carnitine isopropyl ester on the actions of BAY K 8644 and norepinephrine in the perfused rat heart.
    Reeves KA; Rad-Niknam M; Dewar GH; Woodward B
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):864-70. PubMed ID: 7564330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
    Cohen C; Perrault G; Sanger DJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
    Asano M; Aoki K; Suzuki Y; Matsuda T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega 3 polyunsaturated fatty acid modulates dihydropyridine effects on L-type Ca2+ channels, cytosolic Ca2+, and contraction in adult rat cardiac myocytes.
    Pepe S; Bogdanov K; Hallaq H; Spurgeon H; Leaf A; Lakatta E
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8832-6. PubMed ID: 7522322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats].
    Kawasaki H
    Hokkaido Igaku Zasshi; 1997 Nov; 72(6):649-65. PubMed ID: 9465317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.